These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31821742)

  • 1. Combined use of multiparametric flow cytometry and cytomorphology to enhance detection of neuroblastoma metastatic cells in bone marrow.
    Manenq C; Lesesve JF; Dreumont N; Massin F; Salignac S; Mansuy L; Chastagner P; Latger-Cannard V; Broséus J
    Int J Lab Hematol; 2020 Feb; 42(1):52-60. PubMed ID: 31821742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma.
    Popov A; Druy A; Shorikov E; Verzhbitskaya T; Solodovnikov A; Saveliev L; Tytgat GAM; Tsaur G; Fechina L
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):535-542. PubMed ID: 30603901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.
    Scaruffi P; Morandi F; Gallo F; Stigliani S; Parodi S; Moretti S; Bonassi S; Fardin P; Garaventa A; Zanazzo G; Pistoia V; Tonini GP; Corrias MV
    Pediatr Blood Cancer; 2012 Jul; 59(1):44-51. PubMed ID: 21994039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.
    Swerts K; De Moerloose B; Dhooge C; Brichard B; Benoit Y; Laureys G; Philippé J
    Cytometry B Clin Cytom; 2004 Sep; 61(1):9-19. PubMed ID: 15351977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Analysis of Flow Cytometry and Cytomorphology for Neuroblastoma Cell Detection in Effusion and Bone Marrow Specimens.
    Ye W; Wang J; Li W; Shen H
    Fetal Pediatr Pathol; 2019 Feb; 38(1):1-7. PubMed ID: 30667298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma.
    Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M
    Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma.
    Bozzi F; Collini P; Aiello A; Barzanò E; Gambirasio F; Podda M; Meazza C; Ferrari A; Luksch R
    Anticancer Res; 2008; 28(3A):1565-9. PubMed ID: 18630512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction.
    Tsang KS; Li CK; Tsoi WC; Leung Y; Shing MM; Chik KW; Lee V; Ng MH; Yuen P
    Cancer; 2003 Jun; 97(11):2887-97. PubMed ID: 12767104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of bone marrow CD56
    Theodorakos I; Paterakis G; Papadakis V; Vicha A; Topakas G; Jencova P; Karchilaki E; Taparkou A; Tsagarakis NJ; Polychronopoulou S
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27799. PubMed ID: 31066205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry.
    Bozzi F; Gambirasio F; Luksch R; Collini P; Brando B; Fossati-Bellani F
    Anticancer Res; 2006; 26(5A):3281-7. PubMed ID: 17094441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
    Dondero A; Morini M; Cangelosi D; Mazzocco K; Serra M; Spaggiari GM; Rotta G; Tondo A; Locatelli F; Castellano A; Scuderi F; Sementa AR; Eva A; Conte M; Garaventa A; Bottino C; Castriconi R
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new sensitive and specific combination of CD81/CD56/CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry.
    Nagai J; Ishida Y; Koga N; Tanaka Y; Ohnuma K; Toyoda Y; Katoh A; Hayabuchi Y; Kigasawa H
    J Pediatr Hematol Oncol; 2000; 22(1):20-6. PubMed ID: 10695817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow.
    Okcu MF; Wang RY; Bueso-Ramos C; Schober W; Weidner D; Andrassy R; Blakely M; Russell H; Ozkan A; Kuttesch J; Andreeff M; Chan KW; Ater J
    Pediatr Blood Cancer; 2005 Nov; 45(6):787-95. PubMed ID: 15929127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of differentiating neuroblasts in bone marrow is a favorable prognostic factor for bone marrow metastatic neuroblastoma at diagnosis.
    Park SH; Kim S; Park CJ; Jang S; Chi HS; Koh KN; Im HJ; Seo JJ
    Ann Lab Med; 2013 Mar; 33(2):89-96. PubMed ID: 23483759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
    Berois N; Blanc E; Ripoche H; Mergui X; Trajtenberg F; Cantais S; Barrois M; Dessen P; Kågedal B; Bénard J; Osinaga E; Raguénez G
    Clin Chem; 2006 Sep; 52(9):1701-12. PubMed ID: 16873292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of immunocytological GD2 expression on neuroblastoma cells in bone marrow at diagnosis, during treatment, and at recurrence.
    Schumacher-Kuckelkorn R; Volland R; Gradehandt A; Hero B; Simon T; Berthold F
    Pediatr Blood Cancer; 2017 Jan; 64(1):46-56. PubMed ID: 27654028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of bone marrow lesions in children with neuroblastoma detected by flow cytometry].
    Popov AM; Shorikov EV; Verzhditskaia TIu; Tsaur GA; Druĭ AE; Solodovnikov AG; Savel'ev LI; Fechina LG
    Vopr Onkol; 2014; 60(4):469-75. PubMed ID: 25552066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
    Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
    [No Abstract]   [Full Text] [Related]  

  • 19. [The TH, ELAVL4 and GD2 gene expression as diagnostic markers of bone marrow lesions in patients with neuroblastoma].
    Druĭ AE; Tsaur GA; Popov AM; Tuponogov SN; Shorikov EV; Tsvirenko SV; Savel'ev LI; Fechina LG
    Vopr Onkol; 2012; 58(4):514-20. PubMed ID: 23607207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.